Beyond the antigen receptor: editing the genome of T-cells for cancer adoptive cellular therapies.
about
RNA Interference in the Age of CRISPR: Will CRISPR Interfere with RNAi?CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients.Targeting CD73 in the tumor microenvironment with MEDI9447.Purity of transferred CD8(+) T cells is crucial for safety and efficacy of combinatorial tumor immunotherapy in the absence of SHP-1.Synthetic biology in cell-based cancer immunotherapy.Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9.SHP-1: the next checkpoint target for cancer immunotherapy?Chimeric antigen receptors for treatment of glioblastoma: a practical review of challenges and ways to overcome them.Cornerstones of CRISPR-Cas in drug discovery and therapy.CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer.Bench, bedside, toolbox: T-cells deliver on every level.CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells for adoptive therapy.PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?Extracellular ISG15 Signals Cytokine Secretion through the LFA-1 Integrin Receptor.Translation of CRISPR Genome Surgery to the Bedside for Retinal Diseases.Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma
P2860
Q26765460-BE3147EB-6371-44FF-A9A4-2F50979AEBC7Q36512076-219E9AC1-F468-4F17-952C-98A87DB01BB7Q37224639-2363EDA5-BD75-455D-9BD7-4639E4E60977Q37263972-BA95A1C8-E4DA-40EA-A013-228493F737A6Q38531361-BC9F1004-2557-480D-9AAF-EFC4534587DAQ38691942-645A739E-04F7-4BE8-A659-5BB123D01F13Q38805738-EE5E3431-CC14-4337-8CB2-BC545584ED1BQ38987239-8B6DD221-85FD-4D3A-9AD4-513B44BF0BCEQ39051110-1E260729-84BB-4945-8D21-DEAC94C49980Q40336060-3FBD1697-21E4-4735-BAFE-DE03264AD21EQ41848527-A85F7813-6E2B-4474-8CBD-1FD9FFC28AF3Q46588562-9645359A-4A77-4644-8932-74C37CF6C623Q47137043-09E19CD3-6D58-471B-A321-066412141B23Q47444950-F43B9DCB-FB20-4478-872C-AB7667E895F8Q55180016-8EBF7CBA-AF17-4D1A-B195-631ED0B1603CQ57486613-BD522E53-3FD6-4580-95A4-E26B1EB3E54F
P2860
Beyond the antigen receptor: editing the genome of T-cells for cancer adoptive cellular therapies.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Beyond the antigen receptor: e ...... r adoptive cellular therapies.
@en
type
label
Beyond the antigen receptor: e ...... r adoptive cellular therapies.
@en
prefLabel
Beyond the antigen receptor: e ...... r adoptive cellular therapies.
@en
P2860
P356
P1476
Beyond the antigen receptor: e ...... er adoptive cellular therapies
@en
P2093
Angharad Lloyd
Bruno Laugel
P2860
P356
10.3389/FIMMU.2013.00221
P577
2013-08-05T00:00:00Z